Lymphocyte immunotherapy can improve pregnancy outcome following embryo transfer (ET) in patients failing to conceive after two previous ET

Clinical and Experimental Obstetrics and Gynecology

Volumn 32, Issue 1, 2005, Pages 21-22

  Check, J H ^a,b   Liss, J R ^a   Check, M L ^a   Diantonio, A ^a   Duroseau, M ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b NONE   (United States)

Author keywords

Embryo transfer; Live delivery; Lymphocyte immunotherapy

Indexed keywords

FOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCEPTION; CONTROLLED STUDY; DELIVERY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPHOCYTE IMMUNOTHERAPY; MALE; PREGNANCY; PREGNANCY RATE; TREATMENT OUTCOME;

ADULT; EMBRYO TRANSFER; FEMALE; HUMANS; IMMUNOTHERAPY; INFERTILITY, FEMALE; LEUKOCYTE TRANSFUSION; MATCHED-PAIR ANALYSIS; PREGNANCY; PREGNANCY RATE;

EID: 17444382404     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Check J.H., Szekres-Bartho J., O'Shaughnessy A.: "Progesterone induced blocking factor seen in pregnancy lymphocytes soon after implantation". Am. J. Reprod. Immunol., 1996, 35, 277.
2. Check J.H., Arwitz M., Gross J., Peymer M., Szekeres-Bartho J.: "Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF)". Am. J. Reprod. Immunol., 1997, 37, 17.
3. Scott J.R.: "Immunotherapy for recurrent miscarriage". Cochrane Database Syst Rev 01-Jan-2003 (1), CD000112.
4. Szekeres-Bartho J., Varga P., Retjsik B.: "ELISA test for detecting a progesterone-induced immunological factor in pregnancy serum". J. Reprod. Immunol., 1989, 16, 19.
5. Szekeres-Bartho J., Faust Z., Varga P.: "The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes". Am. J. Reprod. Immunol., 1995, 34, 342.
6. Check J.H., Ostrzenski A., Klimek R.: "Expression of an immunomodulatory protein known as progesterone induced blocking factor (PIBF) does not correlate with first trimester spontaneous abortions in progesterone supplemented women". Am. J. Reprod. Immunol., 1997, 37, 330.
7. Check J.H., Tarquini P., Gandy P., Lauer C.: "A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment versus progesterone alone in primary habitual aborters". Gynecol. Obstet. Invest., 1995, 39, 257.